TPA
ENZ
Trivium Point Advisory’s Enzo Biochem, Inc. ENZ Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-19,500
| Closed | -$7.22K | – | 364 |
|
|
2025
Q1 | $7.22K | Hold |
19,500
| – | – | ﹤0.01% | 336 |
|
|
2024
Q4 | $13.9K | Hold |
19,500
| – | – | ﹤0.01% | 337 |
|
|
2024
Q3 | $22.2K | Buy |
+19,500
| New | +$22.2K | ﹤0.01% | 325 |
|
|
2024
Q2 | – | Sell |
-19,500
| Closed | -$24.8K | – | 310 |
|
|
2024
Q1 | $24.8K | Hold |
19,500
| – | – | 0.01% | 212 |
|
|
2023
Q4 | $27.1K | Hold |
19,500
| – | – | 0.01% | 194 |
|
|
2023
Q3 | $26.3K | Hold |
19,500
| – | – | 0.01% | 184 |
|
|
2023
Q2 | $35.9K | Hold |
19,500
| – | – | 0.01% | 189 |
|
|
2023
Q1 | $47.4K | Buy |
19,500
+1,000
| +5% | +$2.43K | 0.01% | 179 |
|
|
2022
Q4 | $25.9K | Buy |
18,500
+500
| +3% | +$700 | 0.01% | 181 |
|
|
2022
Q3 | $41K | Hold |
18,000
| – | – | 0.01% | 180 |
|
|
2022
Q2 | $39K | Hold |
18,000
| – | – | 0.01% | 193 |
|
|
2022
Q1 | $53K | Hold |
18,000
| – | – | 0.01% | 220 |
|
|
2021
Q4 | $58K | Hold |
18,000
| – | – | 0.01% | 239 |
|
|
2021
Q3 | $70K | Hold |
18,000
| – | – | 0.02% | 218 |
|
|
2021
Q2 | $57K | Hold |
18,000
| – | – | 0.01% | 209 |
|
|
2021
Q1 | $62K | Hold |
18,000
| – | – | 0.02% | 188 |
|
|
2020
Q4 | $48K | Hold |
18,000
| – | – | 0.01% | 179 |
|
|
2020
Q3 | $38K | Buy |
18,000
+400
| +2% | +$844 | 0.01% | 162 |
|
|
2020
Q2 | $43K | Hold |
17,600
| – | – | 0.02% | 154 |
|
|
2020
Q1 | $42K | Buy |
17,600
+425
| +2% | +$1.01K | 0.02% | 139 |
|
|
2019
Q4 | $45K | Hold |
17,175
| – | – | 0.02% | 159 |
|
|
2019
Q3 | $60K | Hold |
17,175
| – | – | 0.03% | 157 |
|
|
2019
Q2 | $58K | Hold |
17,175
| – | – | 0.03% | 161 |
|
|
2019
Q1 | $47K | Hold |
17,175
| – | – | 0.02% | 155 |
|
|
2018
Q4 | $48K | Buy |
+17,175
| New | +$48K | 0.03% | 137 |
|